Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22534,179,1.04 [0.85-1.26],0.7220162741462364
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23560,188,1.11 [0.92-1.34],0.2549077797319422
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23315,1399,1.07 [1.00-1.15],0.0410430713686916
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Candidiasis,23573,372,1.03 [0.90-1.18],0.7008780398732184
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22881,3443,1.06 [1.01-1.10],0.0165618970383127
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22847,3461,1.04 [0.99-1.08],0.1172698633120434
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23359,1042,1.03 [0.95-1.11],0.5057960767120806
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23495,78,0.96 [0.71-1.30],0.7769678012753494
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21376,1115,1.07 [0.99-1.16],0.0785289405853114
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20623,1231,1.07 [0.99-1.15],0.0677335057824431
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20345,249,1.03 [0.87-1.21],0.7523940751391401
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16576,2248,1.05 [0.99-1.11],0.1214305481191042
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20274,405,1.12 [0.99-1.27],0.0706744796380202
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23563,1246,1.05 [0.97-1.13],0.2097861605854372
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Mycoses,23664,463,1.04 [0.92-1.18],0.5002400345917557
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22807,891,1.09 [1.00-1.19],0.0417511657492857
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23587,1232,1.05 [0.98-1.13],0.1878947847137426
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22507,190,1.10 [0.91-1.33],0.3109856230076637
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23703,53,0.94 [0.65-1.36],0.7513749898402899
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23432,1077,1.07 [0.99-1.16],0.0856796849510856
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23489,72,1.33 [1.01-1.76],0.0415688734848842
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23639,122,1.10 [0.87-1.38],0.4341871931693091
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23618,101,1.21 [0.95-1.54],0.1177840186577001
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22402,486,1.10 [0.98-1.23],0.1223228309536764
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22201,285,0.99 [0.84-1.15],0.8640194573314859
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22407,90,1.18 [0.91-1.54],0.2151662384521445
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23685,68,0.87 [0.62-1.20],0.3898213973798592
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23648,141,1.02 [0.82-1.27],0.8777282464218665
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Viral warts,23559,52,1.06 [0.74-1.52],0.7526478963938454
BID,BH3-interacting domain death agonist,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23557,50,0.93 [0.63-1.35],0.6964104506851038
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign lipomatous neoplasm,23394,346,0.93 [0.80-1.07],0.3151304728348821
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23632,46,0.83 [0.55-1.25],0.3682553627699474
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23602,55,1.09 [0.78-1.54],0.6076238868241637
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23655,131,0.95 [0.75-1.20],0.6810016373030854
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23331,1631,1.02 [0.95-1.09],0.6067598523487778
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm of meninges,23703,32,0.78 [0.48-1.28],0.3253423758510549
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23641,66,1.15 [0.84-1.57],0.3745899233202622
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23687,78,1.06 [0.79-1.42],0.6893098924224856
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23678,439,0.95 [0.83-1.07],0.3860450831823643
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Caecum,23673,338,1.05 [0.92-1.21],0.468481125222185
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23573,82,1.02 [0.77-1.37],0.8688810002944409
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Descending colon,23671,275,1.04 [0.89-1.21],0.6396004287095092
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Rectum,23631,422,0.90 [0.79-1.03],0.1372737592823219
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23580,726,1.02 [0.93-1.13],0.6487164511742964
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23659,553,1.05 [0.94-1.17],0.3833091415600655
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18427,71,0.99 [0.72-1.35],0.9442738205873856
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18427,71,0.70 [0.50-0.99],0.0410369050556586
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23672,101,1.23 [0.97-1.57],0.0865609787862669
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Haemangioma, any site",23672,98,1.25 [0.98-1.59],0.0761752834461396
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Lung cancer and mesothelioma,15774,340,1.27 [1.11-1.45],0.000531138971518
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Lymphoid leukaemia,18420,64,1.19 [0.87-1.63],0.2684747356276546
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18553,197,0.98 [0.81-1.19],0.8741996464487658
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18646,290,0.97 [0.83-1.13],0.6932847479314006
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18449,93,0.89 [0.67-1.19],0.4449355789465763
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18497,141,1.04 [0.83-1.29],0.7455732057169256
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18492,136,1.01 [0.80-1.26],0.957927409994136
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18438,82,1.11 [0.83-1.47],0.4762573502676528
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19745,1389,1.03 [0.96-1.11],0.3534284330044052
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18498,142,1.11 [0.89-1.37],0.3485584775884913
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18462,106,1.21 [0.95-1.54],0.116479101558422
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18488,132,1.14 [0.91-1.42],0.260084299371326
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Melanocytic naevi,23577,171,0.84 [0.68-1.04],0.1024446266678041
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Melanocytic naevi of trunk,23672,95,1.00 [0.77-1.31],0.988520436050066
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Melanoma in situ,18389,73,1.05 [0.77-1.43],0.7540553854455359
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18457,101,0.75 [0.57-0.99],0.0459606928470426
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18524,168,0.81 [0.65-1.00],0.0490867668882934
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18575,219,1.26 [1.07-1.49],0.0057969912345337
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18457,101,0.72 [0.54-0.96],0.0239194910349486
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,Other benign neoplasms of skin,23570,140,1.09 [0.88-1.35],0.4332138626373916
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19553,1197,1.01 [0.94-1.09],0.8123817376366148
BID,BH3-interacting domain death agonist,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19629,1273,1.01 [0.94-1.09],0.8193137299649671
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23425,307,0.99 [0.85-1.15],0.8602342114787593
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21983,120,0.85 [0.66-1.09],0.2034251778038028
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23190,72,0.87 [0.63-1.20],0.3937784254031401
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23141,2758,1.00 [0.95-1.05],0.9075972098721417
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22432,58,1.24 [0.90-1.70],0.1941982813725323
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23285,51,0.83 [0.56-1.22],0.3422709452048869
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23325,1462,1.01 [0.94-1.08],0.7692324972668412
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23323,1460,1.01 [0.94-1.08],0.7856027449427956
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21966,103,0.95 [0.73-1.24],0.7152738404618673
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23464,1090,1.06 [0.98-1.14],0.1654329441000025
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23333,99,1.00 [0.76-1.30],0.974344949220714
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23195,77,1.04 [0.77-1.39],0.8007183050088666
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23179,61,1.09 [0.79-1.52],0.5930823383104793
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23543,309,0.72 [0.62-0.85],9.024255389572828e-05
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23607,48,0.81 [0.55-1.21],0.3056432178508764
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23486,252,0.65 [0.54-0.78],3.036040354500531e-06
BID,BH3-interacting domain death agonist,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22452,78,0.92 [0.67-1.25],0.5839880477942627
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17473,376,1.05 [0.92-1.20],0.4826065945366667
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21674,164,1.10 [0.91-1.34],0.3168093002443195
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21699,189,1.08 [0.90-1.29],0.4182663067356738
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,17154,57,0.97 [0.68-1.39],0.8803029273715812
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22332,65,0.82 [0.58-1.15],0.2449801351025463
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21564,219,0.90 [0.75-1.09],0.2820487003671522
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23202,609,0.94 [0.84-1.05],0.2768937015846522
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22831,238,0.94 [0.79-1.13],0.5232434864048884
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22760,167,0.97 [0.79-1.19],0.785278471544564
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23400,1133,1.09 [1.02-1.18],0.0183667322125609
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20289,1089,1.08 [1.00-1.17],0.0379333848756944
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",17171,74,0.79 [0.57-1.10],0.1587181869411531
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22834,39,0.83 [0.53-1.29],0.4030705132683222
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17365,268,1.19 [1.02-1.39],0.0260058451921792
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,17172,75,1.25 [0.95-1.65],0.109748235252007
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20957,3860,1.07 [1.02-1.11],0.0025090241176185
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17283,186,1.02 [0.84-1.23],0.8677602880662694
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17663,566,1.13 [1.02-1.26],0.0251338901412605
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23645,277,1.04 [0.89-1.21],0.6493890383307749
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23458,90,1.15 [0.89-1.50],0.2937290587528565
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,17249,152,1.14 [0.93-1.40],0.1966036281623127
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",17162,65,0.76 [0.54-1.08],0.1308602147161714
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23527,732,0.99 [0.89-1.09],0.7663826440547421
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17400,303,1.08 [0.93-1.25],0.3402014607749979
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17478,381,0.91 [0.79-1.05],0.2089700276481816
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17824,727,1.04 [0.95-1.15],0.3868342459601313
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,17243,146,0.84 [0.67-1.06],0.1468516187313573
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23451,83,1.21 [0.92-1.58],0.1709394876517463
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17659,562,1.10 [0.99-1.23],0.0831878063884268
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17480,383,1.12 [0.99-1.28],0.080184463010305
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21414,69,1.09 [0.81-1.48],0.5620677311127587
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22266,5169,1.06 [1.02-1.10],0.0027912148985762
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22815,20,0.72 [0.38-1.36],0.3151856111788165
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22816,21,0.86 [0.47-1.57],0.6237421860480883
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23531,1772,0.97 [0.91-1.03],0.342255931496943
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23528,1768,0.97 [0.91-1.03],0.3541625301053838
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22817,22,1.20 [0.72-2.01],0.4838181451558478
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23431,789,1.00 [0.91-1.09],0.9595268226876658
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18701,1604,1.04 [0.98-1.11],0.206592715288555
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23692,268,0.91 [0.77-1.07],0.2431858473681763
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22700,107,1.08 [0.84-1.39],0.5416754577218299
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22718,76,1.26 [0.96-1.66],0.0911029419122511
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22725,83,1.19 [0.91-1.56],0.2012194063251461
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",17161,64,1.00 [0.72-1.39],0.9940786047278622
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20916,161,0.83 [0.67-1.03],0.0963075235668916
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2500,123,0.89 [0.70-1.14],0.3689578855667269
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2664,320,0.88 [0.76-1.03],0.1047637609636362
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20854,99,0.95 [0.72-1.24],0.6893024399539337
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2457,82,0.83 [0.61-1.14],0.2512271536650688
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22920,2165,1.07 [1.02-1.13],0.0114305129277375
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22950,357,0.86 [0.74-1.00],0.0441094881900957
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21583,238,0.96 [0.81-1.14],0.6145390133912516
BID,BH3-interacting domain death agonist,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17896,799,1.03 [0.94-1.13],0.540342242096927
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23580,251,0.95 [0.81-1.13],0.5894433645140422
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22484,271,0.95 [0.80-1.11],0.5117022455364327
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Angina pectoris,20794,1490,0.98 [0.91-1.04],0.4746691166635187
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22592,379,0.98 [0.85-1.12],0.7686174992076554
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22296,83,1.08 [0.82-1.44],0.5778467962848719
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22459,246,0.99 [0.84-1.18],0.9524016720929764
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13867,2299,0.95 [0.90-1.00],0.0642137540752459
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,AV-block,19070,623,0.97 [0.87-1.08],0.5497467236558917
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23627,534,0.86 [0.77-0.97],0.0163213201150375
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Cardiac arrest,11819,251,1.09 [0.92-1.28],0.3182274401980067
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18651,204,0.90 [0.74-1.09],0.2658788302648376
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18559,112,0.85 [0.66-1.10],0.2217114302387281
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23704,67,1.16 [0.86-1.58],0.328802166952393
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Conduction disorders,19803,1356,0.98 [0.91-1.05],0.5538344559613657
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21900,2619,1.03 [0.98-1.08],0.2935119013020024
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19952,7728,1.04 [1.01-1.07],0.0186509122214091
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22480,273,0.93 [0.79-1.10],0.4172747842881263
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Endocarditis,18531,84,1.07 [0.81-1.42],0.6222489745576497
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23396,1317,0.98 [0.91-1.05],0.5780836789565618
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Hypertension,21151,6737,1.06 [1.02-1.09],0.0007653313366597
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21175,6761,1.05 [1.02-1.09],0.0009116201410936
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23474,112,0.72 [0.55-0.94],0.0175944888671896
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14598,184,0.95 [0.78-1.16],0.6128410502788684
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14582,168,0.97 [0.79-1.19],0.7526772847874004
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Hypotension,23558,1232,1.09 [1.02-1.18],0.0177837985648271
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22632,118,0.88 [0.68-1.13],0.31362574941925
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22041,2737,1.01 [0.96-1.06],0.694247001513718
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23271,651,1.08 [0.97-1.19],0.1443398398822382
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18865,418,0.99 [0.86-1.12],0.8212191671918989
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22976,1062,1.02 [0.94-1.11],0.5649649119477971
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",20224,920,1.03 [0.95-1.13],0.4462856598414666
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23540,221,1.04 [0.87-1.23],0.6880224380257562
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23655,373,0.93 [0.81-1.07],0.3066802330386363
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Oesophageal varices,22278,71,0.90 [0.65-1.24],0.5229727779365619
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other aneurysm,22309,96,0.94 [0.72-1.24],0.6693773847176844
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other arrhythmias,18923,476,0.94 [0.84-1.07],0.3662899943333544
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22345,132,1.19 [0.96-1.47],0.1161991546623023
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22489,276,0.87 [0.74-1.03],0.1006796435120132
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18643,196,1.05 [0.87-1.26],0.6130237646131839
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other disorders of veins,22305,98,0.97 [0.74-1.27],0.8297723806449653
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22257,50,1.05 [0.73-1.51],0.8079180965534853
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22119,90,1.03 [0.78-1.36],0.8306193514884622
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22313,106,1.05 [0.82-1.35],0.6938758227912316
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19693,1246,0.90 [0.83-0.97],0.0087696178781953
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22391,65,0.77 [0.54-1.09],0.1354488934569906
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22780,567,1.07 [0.96-1.19],0.2349256314790312
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23055,364,1.03 [0.90-1.18],0.6976926180182674
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22695,666,1.01 [0.91-1.12],0.8502936474897259
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11942,374,0.82 [0.71-0.95],0.0063686536309638
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22693,527,1.04 [0.93-1.16],0.5257728920976124
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22560,353,0.91 [0.79-1.06],0.2231953085600749
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23192,501,0.97 [0.86-1.09],0.5993575012319567
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23643,710,0.91 [0.82-1.01],0.0642008444751615
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Right bundle-branch block,18913,466,1.00 [0.89-1.14],0.936379868592212
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23053,362,1.02 [0.89-1.17],0.7742906168087144
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22254,225,1.13 [0.95-1.34],0.1611177045417132
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23255,741,1.05 [0.96-1.16],0.2789866491722426
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23239,769,1.05 [0.96-1.15],0.2987957337611077
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22609,45,0.80 [0.53-1.21],0.2922468360930554
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22326,114,0.91 [0.71-1.18],0.4769418278582314
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22872,252,1.10 [0.94-1.30],0.229130071781686
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22229,315,1.07 [0.92-1.24],0.3657733155882262
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Varicose veins,22586,379,0.93 [0.81-1.06],0.2781138412376748
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22230,74,0.81 [0.58-1.11],0.1902838745403461
BID,BH3-interacting domain death agonist,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23466,782,0.94 [0.85-1.03],0.1910577544443295
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23509,497,1.07 [0.96-1.20],0.2198880600485572
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20376,957,1.05 [0.97-1.14],0.2396519462656549
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,Any mental disorder,23021,3602,1.03 [0.99-1.08],0.1808683465144284
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23447,585,1.08 [0.98-1.20],0.1235145908824714
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20587,1168,1.07 [0.99-1.15],0.0714489586760856
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19502,83,1.02 [0.77-1.35],0.8973986521158182
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,Smoking dependency,23066,1523,1.07 [1.00-1.14],0.0459026869621294
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21282,1863,1.06 [1.00-1.12],0.0515278725464844
BID,BH3-interacting domain death agonist,Chapter V Mental and behavioural disorders,Vascular dementia,23199,150,0.86 [0.69-1.08],0.206367411776889
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Alzheimer disease,23702,294,0.95 [0.81-1.11],0.5308338893965463
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",15756,58,1.09 [0.78-1.53],0.5987043655414324
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Bell's palsy,22330,77,1.17 [0.88-1.55],0.285078542328938
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22597,344,1.14 [1.00-1.31],0.0518196108980374
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Cerebral cysts,23302,237,0.95 [0.79-1.13],0.5282505812712217
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23616,364,1.03 [0.90-1.18],0.6292966938329911
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23198,59,0.97 [0.68-1.37],0.858036467439816
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23683,72,0.86 [0.62-1.19],0.3583609143184417
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23155,90,1.01 [0.77-1.33],0.9318787115223236
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Epilepsy,22092,286,0.97 [0.83-1.14],0.7385728299273695
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23169,1363,1.00 [0.93-1.07],0.9436407891085384
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23667,677,0.97 [0.87-1.07],0.5137290089655547
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23154,2197,0.98 [0.92-1.03],0.396547053188599
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Generalized epilepsy,23316,59,1.07 [0.76-1.49],0.7079811114219821
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Hemiplegia,23533,281,1.05 [0.90-1.23],0.516608893454912
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Hydrocephalus,23121,56,1.09 [0.77-1.53],0.6376630375433162
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23685,59,1.07 [0.77-1.50],0.6940350726896101
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22274,21,0.65 [0.35-1.23],0.1882032454869823
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22347,94,1.13 [0.88-1.47],0.3414891818652851
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Memory loss,23037,118,0.87 [0.68-1.12],0.2937059941725132
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Migraine,21999,193,0.99 [0.82-1.19],0.9049437733324508
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23679,173,1.01 [0.82-1.23],0.9505290626224988
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Motor neuron disease,15861,150,1.17 [0.95-1.43],0.1371092817485885
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23594,61,0.86 [0.60-1.21],0.3798052204010597
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23235,982,1.08 [1.00-1.17],0.0633966154179734
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Neurological diseases,22394,3661,1.01 [0.97-1.06],0.5201046368742432
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23379,240,1.00 [0.84-1.19],0.995223620900633
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22645,392,1.06 [0.93-1.21],0.3954084855947376
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23608,355,0.99 [0.86-1.14],0.8779378579551741
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18585,615,0.97 [0.87-1.08],0.5333659500286358
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23143,78,0.98 [0.73-1.32],0.8934232105252171
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23219,154,0.91 [0.73-1.14],0.418150025904237
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23125,135,0.87 [0.69-1.11],0.2642421478747702
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22349,96,1.16 [0.90-1.50],0.2404939853975212
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other headache syndromes,21845,39,0.71 [0.45-1.11],0.134946198944003
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other neurological diseases,23587,522,0.99 [0.88-1.11],0.8016617761449059
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Other sleep disorders,22508,702,0.98 [0.88-1.08],0.6268595813083528
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Parkinson's disease,23681,533,1.00 [0.89-1.12],0.9471874053664197
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23092,27,0.91 [0.54-1.53],0.7087307285364759
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Restless leg syndrome,23703,47,0.95 [0.64-1.40],0.7895468903397392
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Sleep apnoea,23400,632,0.97 [0.88-1.08],0.5810960146809827
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23310,57,0.96 [0.67-1.37],0.8189254063151669
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23685,176,1.14 [0.94-1.38],0.1731867303150939
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22288,35,0.78 [0.49-1.25],0.3084085135383709
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23702,297,0.95 [0.81-1.11],0.5299224865586505
BID,BH3-interacting domain death agonist,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23168,146,0.85 [0.67-1.07],0.1646133118900478
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23157,86,1.00 [0.76-1.33],0.9801211500381302
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23359,297,0.92 [0.78-1.07],0.2867327998320976
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23505,294,0.87 [0.74-1.02],0.0886565523214761
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22839,43,0.89 [0.58-1.35],0.5720058375706804
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22858,62,1.38 [1.03-1.84],0.0282771109238254
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23612,43,0.86 [0.57-1.31],0.4817118953584117
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23469,120,0.88 [0.68-1.13],0.313720133666304
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2461,84,0.84 [0.62-1.13],0.2486709332448306
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2997,131,0.93 [0.73-1.17],0.5304418273545388
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23166,95,1.32 [1.04-1.68],0.0231507690863201
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23454,996,0.98 [0.90-1.07],0.6447070393416843
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23406,610,0.95 [0.86-1.06],0.3997304415714545
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22937,141,0.91 [0.72-1.14],0.3989556423591248
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23628,566,0.97 [0.86-1.08],0.5519964041801396
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23700,65,1.11 [0.81-1.52],0.5109533151078125
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23559,497,0.96 [0.85-1.08],0.5317992778082343
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23665,316,0.94 [0.81-1.09],0.4229352002841594
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23613,149,1.03 [0.84-1.28],0.7564109623394384
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22873,77,1.11 [0.83-1.49],0.4758339783334598
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22877,81,0.77 [0.56-1.05],0.098361183501318
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22838,42,1.08 [0.72-1.62],0.7152369085724446
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23609,674,1.01 [0.91-1.12],0.8417064122851935
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23116,181,0.98 [0.81-1.20],0.8594287232274493
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23091,29,0.85 [0.51-1.42],0.5368052519226405
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23445,96,0.96 [0.73-1.26],0.7871424490201492
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23574,225,0.91 [0.76-1.09],0.2854302605394506
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23230,168,1.11 [0.92-1.35],0.278095953201026
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23548,84,1.10 [0.83-1.45],0.5023040183108605
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23393,458,1.08 [0.96-1.22],0.2100335478884716
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23199,128,1.08 [0.86-1.35],0.5257308736444477
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22328,1782,1.01 [0.95-1.08],0.6549841771517414
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23543,194,0.89 [0.73-1.09],0.2583648352436818
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23688,147,1.06 [0.86-1.32],0.5639791066044122
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23208,412,0.90 [0.79-1.03],0.1382556768310805
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23413,64,0.98 [0.70-1.37],0.916633706261474
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23689,54,1.16 [0.83-1.63],0.3809327260624072
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22874,78,0.86 [0.63-1.17],0.3361212128601109
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22934,138,0.99 [0.79-1.24],0.9117857854950436
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22584,126,1.00 [0.79-1.26],0.9914137565530744
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23113,51,0.82 [0.55-1.21],0.3152862675893809
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22523,65,1.17 [0.85-1.59],0.33602725818821
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22982,47,0.96 [0.65-1.42],0.8392706077746928
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23141,206,1.03 [0.85-1.23],0.7852848924766455
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22914,118,0.94 [0.73-1.21],0.6320120707407753
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22580,122,1.05 [0.84-1.33],0.6539455400714214
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22549,91,0.92 [0.69-1.22],0.5721345608628411
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22013,1467,0.97 [0.91-1.04],0.4333640158493176
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22851,55,0.93 [0.64-1.33],0.6798865708252627
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23460,389,1.13 [0.99-1.28],0.0678770593222424
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23141,70,1.08 [0.80-1.46],0.624028226720079
BID,BH3-interacting domain death agonist,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23240,169,1.02 [0.84-1.25],0.820083016483258
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23525,57,0.85 [0.59-1.22],0.3771810199575475
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23661,118,0.98 [0.77-1.25],0.8480248281927155
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23570,112,1.11 [0.87-1.41],0.3990117809996861
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23518,50,0.91 [0.62-1.33],0.6169809564168487
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23522,54,0.85 [0.59-1.24],0.4056313352016111
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23608,966,1.02 [0.94-1.11],0.581219627963885
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23357,715,1.06 [0.96-1.16],0.2728184451138079
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22773,131,0.77 [0.60-0.98],0.0336865207077586
BID,BH3-interacting domain death agonist,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22727,85,1.07 [0.81-1.41],0.6423167982048629
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Acute pharyngitis,23492,64,0.75 [0.53-1.06],0.1047876548666839
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23618,190,0.87 [0.71-1.05],0.1505780784898233
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23490,62,0.87 [0.61-1.23],0.4216911802399964
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,All influenza,21428,108,0.91 [0.70-1.18],0.457245902413522
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21425,105,0.95 [0.73-1.24],0.7296726397280762
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15539,105,1.14 [0.90-1.46],0.2780207374237236
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Allergic rhinitis,23597,263,1.02 [0.87-1.20],0.7688931188486312
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16523,1434,1.07 [1.00-1.14],0.0552355805452718
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16841,1407,1.07 [1.00-1.15],0.0529727218906416
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23317,149,1.23 [1.01-1.51],0.0369874518332875
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21414,94,1.21 [0.94-1.55],0.1419214874689754
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Bronchiectasis,20599,289,1.01 [0.87-1.18],0.8943211293028732
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20354,44,1.30 [0.91-1.85],0.1516385972728136
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22862,2552,1.05 [1.00-1.11],0.0531515732528606
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22263,78,1.29 [0.99-1.68],0.055816678450716
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Chronic sinusitis,22342,157,1.26 [1.05-1.53],0.0154525183328831
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23485,1300,1.05 [0.98-1.13],0.1603938813969777
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Deviated nasal septum,22323,138,0.97 [0.78-1.21],0.7940545768215568
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21708,5259,1.05 [1.01-1.09],0.0067234329776472
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22576,391,0.99 [0.86-1.12],0.824602454470938
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Early onset COPD,22488,303,1.07 [0.93-1.23],0.3417410557740482
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Emphysema,20659,349,1.07 [0.93-1.22],0.3673078407909853
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22784,339,1.03 [0.89-1.18],0.7156269610780444
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23457,2137,1.07 [1.01-1.13],0.0148941609086889
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Interstitial lung disease,22812,367,1.08 [0.94-1.23],0.2708414686516167
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Later onset COPD,22649,997,1.05 [0.96-1.14],0.2824425522022545
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23685,424,1.09 [0.96-1.24],0.1717688420327239
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Nasal polyp,22330,145,1.26 [1.04-1.54],0.0195020323582637
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23435,1000,1.13 [1.04-1.22],0.0038623299955831
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other diseases of pleura,23425,2178,1.11 [1.05-1.17],0.0002260832072718
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23048,863,1.05 [0.96-1.15],0.2637591307360489
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other pleural conditions,21311,64,1.09 [0.80-1.51],0.5778694035079974
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23609,451,1.08 [0.96-1.22],0.2144871604402373
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23580,1379,1.10 [1.03-1.18],0.0061301019673071
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Pleural effusion,22363,1116,1.10 [1.02-1.19],0.0128718397241121
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Pleural plaque,21508,261,1.10 [0.94-1.30],0.2179010251845206
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23195,1875,1.08 [1.02-1.15],0.0096794612118739
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23586,325,1.08 [0.94-1.25],0.2690357492823206
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Pneumothorax,21388,141,1.08 [0.87-1.34],0.4765375722855649
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Pollen allergy,23688,229,1.06 [0.89-1.25],0.5328576645336487
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Pulmonary oedema,23226,68,0.92 [0.66-1.28],0.6221662597889136
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15490,56,1.30 [0.94-1.79],0.114677639484376
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23419,984,1.12 [1.03-1.21],0.0070281964837814
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22450,265,1.04 [0.89-1.22],0.6406739902904492
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Viral pneumonia,21602,282,0.98 [0.83-1.14],0.7591167766453435
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23334,239,0.91 [0.77-1.09],0.312988756322022
BID,BH3-interacting domain death agonist,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10326,116,0.93 [0.73-1.19],0.5584251863240295
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16544,88,1.29 [1.00-1.67],0.0482367473483277
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Acute appendicitis,23570,144,1.05 [0.85-1.30],0.6429393112434212
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Acute gastritis,17888,90,1.43 [1.13-1.82],0.0034259094162427
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Acute pancreatitis,22359,202,0.94 [0.78-1.14],0.5350068560839384
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Acute peritonitis,23344,100,0.91 [0.70-1.20],0.5109054189501167
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22815,113,0.92 [0.71-1.18],0.4971383821057391
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Barrett oesophagus,18323,525,0.90 [0.80-1.01],0.0799142800838459
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22278,121,0.94 [0.73-1.20],0.5932623509780517
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23302,121,0.93 [0.73-1.19],0.581579205317919
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Cholecystitis,22371,214,0.98 [0.82-1.18],0.8614906461093463
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Cholelithiasis,22938,781,1.01 [0.92-1.11],0.8484670992609437
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Chronic gastritis,18063,265,0.86 [0.73-1.02],0.0895566647304603
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22212,55,0.87 [0.60-1.26],0.462445780018923
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23495,133,0.62 [0.48-0.80],0.0002500772787952
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Coeliac disease,22074,91,0.84 [0.63-1.12],0.2422014629439723
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Collagenous colitis,22272,50,1.17 [0.83-1.66],0.3697252262169872
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23540,221,1.05 [0.88-1.25],0.5726009900794804
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Constipation,23540,1592,1.02 [0.96-1.09],0.494502942301671
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Crohn disease,22313,91,1.22 [0.95-1.58],0.1202480922611412
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23364,66,1.23 [0.91-1.65],0.1780753689221883
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22298,76,1.25 [0.95-1.64],0.1149454707359617
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Dental caries,23061,221,1.16 [0.99-1.37],0.0699678317240007
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20069,1933,1.00 [0.94-1.06],0.9624299659163033
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of appendix,23601,175,1.00 [0.82-1.22],0.9651120353184752
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of liver,23562,860,0.97 [0.88-1.06],0.4418481447781412
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21711,3913,0.99 [0.95-1.04],0.7854610327864417
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23344,504,1.05 [0.94-1.18],0.3610996606695984
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23653,409,0.97 [0.85-1.11],0.6697230873608446
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22948,108,1.04 [0.81-1.33],0.7574679737812138
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22808,67,1.01 [0.73-1.38],0.9746991322630694
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23391,1408,1.02 [0.95-1.10],0.5181252146339947
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diseases of tongue,22827,105,1.00 [0.77-1.29],0.992586197329789
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23334,1177,0.99 [0.92-1.07],0.8797686628622253
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19492,3036,1.00 [0.95-1.05],0.8959358538012557
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Duodenal ulcer,18061,263,0.89 [0.75-1.05],0.1694670189851821
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23587,208,0.89 [0.74-1.07],0.2233526510912303
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23629,45,1.06 [0.72-1.55],0.7612102816637252
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22858,156,0.66 [0.52-0.83],0.0004649226320286
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16638,182,0.99 [0.82-1.21],0.9517198198227568
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Functional dyspepsia,18217,419,0.93 [0.82-1.06],0.2977373886183774
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Gastric ulcer,18161,363,1.04 [0.90-1.19],0.6220680324862633
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19946,2148,1.00 [0.95-1.06],0.8943582838734486
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18390,592,0.94 [0.84-1.05],0.2944978809350362
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18120,7946,1.01 [0.98-1.05],0.34294890777294
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,GI-bleeding,23155,1172,1.02 [0.94-1.10],0.6993504534564221
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22883,43,1.07 [0.73-1.59],0.7171084830107568
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17420,1233,0.99 [0.92-1.07],0.7671881288182085
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22787,85,0.75 [0.55-1.02],0.0646178633022019
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Hernia,21663,3527,1.01 [0.96-1.05],0.807037531416099
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Impacted teeth,23632,42,1.05 [0.70-1.56],0.8239560770708877
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Impaction of intestines,16503,47,0.96 [0.65-1.42],0.8425866229854198
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Inguinal hernia,19765,1629,1.03 [0.97-1.10],0.3744545333370344
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18333,197,1.02 [0.85-1.23],0.8134905224301309
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16545,89,0.91 [0.68-1.22],0.5342751499947009
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22087,104,0.90 [0.69-1.18],0.4415876648062984
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16728,272,0.90 [0.77-1.07],0.2343859476177565
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23661,373,1.03 [0.90-1.17],0.694858644402926
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22901,679,1.05 [0.95-1.15],0.3832752910014703
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23110,888,1.03 [0.95-1.13],0.4446029017256881
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18011,213,0.95 [0.79-1.14],0.5463291138789427
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Oesophagitis,18420,622,1.01 [0.91-1.12],0.8919955771248277
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23653,114,1.11 [0.88-1.40],0.3927506555473881
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,18213,77,1.01 [0.75-1.37],0.9527785961211168
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17880,1424,1.03 [0.96-1.11],0.387097861397473
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22417,260,0.95 [0.80-1.12],0.5342423921891298
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22281,124,1.07 [0.85-1.34],0.5889721560746104
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of intestine,18319,1863,1.03 [0.97-1.09],0.3806762326077606
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of intestines,21898,5442,1.01 [0.98-1.05],0.5474649303329666
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22793,180,1.11 [0.92-1.34],0.261019998193881
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of liver,23389,687,0.95 [0.86-1.05],0.3415508969857187
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18530,732,0.96 [0.87-1.06],0.4085914298982148
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22300,143,1.00 [0.80-1.24],0.9654225738880134
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23580,336,0.99 [0.86-1.14],0.9062059168754792
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18594,796,0.98 [0.89-1.07],0.6328474435802038
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23167,1184,1.01 [0.94-1.09],0.7598428927926741
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23018,178,1.04 [0.86-1.26],0.7018315538001121
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18083,1627,1.02 [0.95-1.09],0.5779168645615644
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19654,1856,0.98 [0.92-1.04],0.5554273834839911
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22800,98,0.78 [0.58-1.03],0.0789616071846864
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23000,778,1.03 [0.94-1.14],0.4806384506157598
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16807,351,1.04 [0.91-1.20],0.5686523602385756
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23620,54,1.11 [0.79-1.56],0.5614706881684142
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16933,477,1.01 [0.89-1.14],0.9016614299414812
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22148,165,1.25 [1.04-1.50],0.0195120435814819
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23689,44,0.95 [0.63-1.42],0.7869963575096195
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22847,105,1.04 [0.81-1.34],0.7540532411267574
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Toxic colitis,22269,47,0.76 [0.50-1.15],0.1891073245340601
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18092,294,1.04 [0.90-1.22],0.5747080980089836
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Ulcerative colitis,22370,148,1.05 [0.85-1.30],0.629282347367849
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22346,124,1.03 [0.82-1.30],0.7881375737221643
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Umbilical hernia,18509,373,0.94 [0.82-1.08],0.3819113046741756
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16614,158,0.84 [0.68-1.05],0.1312415365771675
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Ventral hernia,18399,263,0.95 [0.81-1.12],0.5570620856199646
BID,BH3-interacting domain death agonist,Chapter XI Diseases of the digestive system,Volvulus,16529,73,0.93 [0.67-1.28],0.6402276522738309
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23627,330,0.90 [0.78-1.05],0.1750039102710313
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23386,67,1.47 [1.12-1.92],0.0047223966641645
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21709,94,0.96 [0.73-1.26],0.7641631786958812
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22971,758,1.02 [0.93-1.12],0.6353086241497955
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22413,200,0.88 [0.73-1.06],0.1760567334782103
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22085,470,1.00 [0.89-1.13],0.9634186848560624
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23409,265,1.05 [0.90-1.23],0.5257093729976108
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23614,470,1.07 [0.95-1.20],0.2917459359002204
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23188,44,1.16 [0.80-1.69],0.4338028799562489
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22221,3167,0.99 [0.95-1.04],0.8169309965612702
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23258,408,0.93 [0.81-1.06],0.2585420262691956
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23148,298,0.88 [0.75-1.03],0.1030040151195608
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23244,1031,1.00 [0.92-1.08],0.9479036996440264
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23693,30,1.24 [0.80-1.92],0.3458321562721601
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21636,21,1.44 [0.89-2.34],0.1349770721782307
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22907,57,1.00 [0.70-1.42],0.9831142215161788
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23404,260,1.05 [0.89-1.23],0.5850956841723374
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22095,480,0.95 [0.84-1.07],0.4164905639404797
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21695,80,0.86 [0.63-1.17],0.340621437710138
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23637,84,1.33 [1.03-1.71],0.0278459393928536
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22430,217,1.06 [0.89-1.27],0.4821459077806167
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23533,214,1.03 [0.86-1.23],0.7357691216018257
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23216,72,0.94 [0.68-1.29],0.6827328512700848
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21681,66,0.85 [0.60-1.19],0.3357044821493312
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23245,1630,1.00 [0.94-1.07],0.9309262649851336
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22134,519,0.94 [0.84-1.06],0.3067222663223819
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21698,83,0.88 [0.65-1.19],0.3976641387136586
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23612,293,1.09 [0.94-1.27],0.2317869021947424
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23197,53,1.24 [0.89-1.73],0.2059962622509631
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23576,257,1.09 [0.93-1.28],0.2758378641489337
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23647,350,0.91 [0.78-1.05],0.187261462515214
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21702,87,0.95 [0.71-1.27],0.7405730183980457
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21884,269,0.86 [0.73-1.02],0.0887624574410091
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23640,343,0.91 [0.79-1.05],0.2077216791786673
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21883,268,1.02 [0.87-1.19],0.8438436219467161
BID,BH3-interacting domain death agonist,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23678,125,1.23 [0.99-1.53],0.0598489890063188
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20471,92,0.95 [0.72-1.26],0.7395854560423345
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21642,4745,1.00 [0.97-1.04],0.8865154891427943
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20246,3349,0.98 [0.94-1.03],0.4008990303481958
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20448,69,0.82 [0.59-1.15],0.2444210932147921
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20810,148,1.00 [0.80-1.24],0.9766387792041654
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20806,144,1.05 [0.85-1.30],0.6550071514200619
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23502,67,1.19 [0.89-1.60],0.2373674192298024
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20741,79,0.98 [0.72-1.32],0.8744518176298658
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17756,859,1.02 [0.93-1.11],0.7152504309364504
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23590,148,1.17 [0.95-1.44],0.1299091574167211
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20930,268,1.06 [0.91-1.25],0.4484219695527529
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20181,6226,1.02 [0.99-1.05],0.2736549933332968
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22646,93,0.96 [0.73-1.26],0.7467213625586053
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20544,165,0.77 [0.62-0.96],0.0213141636709175
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20806,427,1.00 [0.88-1.13],0.961205217241178
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22888,2226,1.03 [0.97-1.08],0.3662361283137922
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20740,361,0.97 [0.84-1.11],0.6513888628431911
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20429,50,1.37 [1.00-1.88],0.0501738901623629
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20472,93,0.87 [0.65-1.16],0.3350680478741136
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23388,30,1.10 [0.69-1.76],0.6825568705182672
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18352,1455,1.01 [0.94-1.08],0.7939040583893752
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17866,969,1.05 [0.96-1.14],0.2797865966803262
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23565,955,1.07 [0.98-1.16],0.1381365441458054
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16945,48,0.85 [0.58-1.26],0.4279894071996301
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16974,77,0.98 [0.72-1.32],0.8831264862109324
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20651,272,1.05 [0.90-1.23],0.5272761829217756
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17526,629,1.09 [0.98-1.20],0.0968738353783305
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20703,41,1.18 [0.80-1.73],0.4042876640898838
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21190,528,1.03 [0.92-1.15],0.6058503221885853
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20930,268,1.09 [0.93-1.28],0.2685806238353752
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17484,587,1.06 [0.95-1.18],0.3009654861898575
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20442,63,1.07 [0.77-1.47],0.7018490907491464
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20431,52,1.03 [0.72-1.48],0.8643929616049438
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22648,95,1.04 [0.80-1.35],0.7753426498007403
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23414,861,0.95 [0.87-1.04],0.2964318701557336
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22953,400,0.93 [0.81-1.06],0.2898774172432433
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23621,284,1.09 [0.93-1.27],0.2783028384376869
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18767,1870,0.99 [0.93-1.05],0.7222062098911941
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16949,52,0.70 [0.47-1.04],0.078259264006549
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20461,82,0.90 [0.67-1.21],0.4782322968150737
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16950,53,1.01 [0.71-1.45],0.9418604884517596
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16940,43,0.68 [0.44-1.04],0.0754776596727615
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22735,182,1.06 [0.88-1.28],0.5290786965641192
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22714,161,0.87 [0.70-1.08],0.1944299094706518
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23667,85,1.02 [0.77-1.36],0.8810341042137986
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22182,1520,1.00 [0.94-1.07],0.9459773232436806
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20444,65,0.92 [0.66-1.28],0.6228769796395284
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16937,40,1.19 [0.81-1.76],0.3693977692348972
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21278,616,1.02 [0.91-1.13],0.7642008554063267
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18604,1707,1.01 [0.94-1.07],0.844756912663546
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23412,54,1.33 [0.96-1.83],0.0847458157714817
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23685,61,1.53 [1.16-2.00],0.002238792862721
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20461,82,1.18 [0.90-1.56],0.2255760046550603
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21356,977,1.07 [0.98-1.16],0.117194228664432
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20474,95,0.92 [0.70-1.21],0.558568946035381
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18087,1190,1.02 [0.94-1.10],0.6671761550178446
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22636,83,0.95 [0.71-1.27],0.7299370661601697
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20423,44,1.04 [0.70-1.54],0.8437042127472074
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20772,110,0.93 [0.72-1.21],0.5858547140030107
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20879,500,0.99 [0.88-1.11],0.8518985524190884
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23549,191,0.99 [0.82-1.20],0.9249317832314636
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21140,478,1.04 [0.92-1.17],0.5619308696516148
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23630,278,1.06 [0.91-1.24],0.4700877352528844
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23689,38,1.40 [0.96-2.03],0.0797500441778976
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20527,148,1.02 [0.82-1.26],0.8722528732166925
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19437,573,1.03 [0.93-1.15],0.5387690296216971
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20859,480,1.07 [0.95-1.20],0.2488381815808859
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20706,327,0.96 [0.83-1.12],0.6324287650622396
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16928,31,1.06 [0.67-1.67],0.7998805765288497
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19139,2242,1.04 [0.99-1.10],0.1551001449286684
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17350,453,0.91 [0.80-1.03],0.1336851558407315
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23520,162,1.00 [0.81-1.23],0.9802430554038593
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23628,46,0.80 [0.53-1.21],0.2890035861287413
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21732,45,0.95 [0.64-1.42],0.8023834856719865
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16960,63,1.44 [1.10-1.89],0.0080544993434488
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20749,87,1.06 [0.80-1.39],0.6882292035492412
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17189,292,1.10 [0.95-1.28],0.1855825042237358
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20653,274,1.01 [0.86-1.18],0.9081449338368632
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20879,217,1.08 [0.91-1.29],0.365475728731756
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20754,92,1.01 [0.76-1.33],0.95224228553777
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18840,31,1.17 [0.76-1.82],0.4771502881011423
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23690,39,1.43 [1.00-2.06],0.0511770777743426
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20906,527,1.03 [0.92-1.16],0.5643647912386183
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23378,20,0.95 [0.52-1.74],0.8705177963600809
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22636,2257,1.02 [0.96-1.07],0.5731479594731428
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20483,104,1.18 [0.93-1.51],0.1754583398653585
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21167,505,0.99 [0.88-1.11],0.8277457113490444
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22652,196,1.00 [0.83-1.21],0.9794989038088544
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20791,129,1.13 [0.90-1.41],0.2799259745169795
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21973,1311,1.05 [0.98-1.13],0.1446758967113627
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21480,818,1.07 [0.97-1.17],0.161796845931857
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20421,42,0.86 [0.57-1.32],0.499400172381418
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23393,35,1.29 [0.87-1.92],0.2109267353459999
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20496,117,1.10 [0.87-1.39],0.4179271992895887
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20400,21,0.74 [0.39-1.37],0.3350197761419213
BID,BH3-interacting domain death agonist,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16956,59,0.74 [0.52-1.07],0.1101579065747145
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22697,1858,1.01 [0.95-1.07],0.7896135045687118
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23223,407,1.03 [0.91-1.18],0.6057476921364193
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22957,141,0.95 [0.75-1.19],0.6312263117456531
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22383,1544,0.94 [0.88-1.01],0.0945171192456254
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23449,84,0.82 [0.60-1.11],0.1934068439751139
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23423,358,0.95 [0.83-1.10],0.5216020270074717
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Cystitis,20832,211,1.01 [0.84-1.21],0.917252629820198
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Dialysis,20946,107,1.31 [1.05-1.65],0.0184572463853806
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22430,3317,0.99 [0.94-1.04],0.649979044154543
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21332,5562,1.00 [0.96-1.03],0.8245189437286615
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23468,103,0.91 [0.70-1.19],0.4878126583177011
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Hydrocele,19322,209,0.85 [0.70-1.03],0.0972057954536808
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,20948,371,1.09 [0.95-1.24],0.2309499151783167
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21715,2602,0.99 [0.94-1.05],0.8156845473522815
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19346,233,0.90 [0.75-1.07],0.242121849303144
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20698,77,0.80 [0.58-1.10],0.1676556133181135
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19225,112,0.90 [0.70-1.16],0.4269614739494138
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23691,61,0.87 [0.61-1.24],0.4508259264163884
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23695,57,0.93 [0.65-1.32],0.6731850647381911
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22869,2248,1.03 [0.97-1.09],0.3470081413690261
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21569,948,1.04 [0.95-1.13],0.3716356911026628
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23627,562,0.98 [0.88-1.10],0.7546474613299193
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19424,311,0.91 [0.78-1.06],0.2434106432112378
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19395,282,1.04 [0.89-1.21],0.6415455762721702
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19344,231,0.87 [0.72-1.04],0.123444215942904
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23686,48,1.14 [0.79-1.64],0.4749082132492102
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22159,1538,1.03 [0.96-1.10],0.4328897774608186
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20992,415,1.08 [0.95-1.22],0.2447764129473061
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23253,188,0.97 [0.80-1.18],0.7598546300897265
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23424,59,1.05 [0.75-1.47],0.791684462486766
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19379,266,0.99 [0.84-1.16],0.8581043068253351
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23400,2823,1.00 [0.95-1.05],0.9335328494235338
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20651,74,1.01 [0.74-1.37],0.9602370493697516
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20995,156,0.93 [0.74-1.15],0.483581050222706
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22894,78,1.10 [0.82-1.46],0.5295061580977395
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20920,299,1.03 [0.89-1.20],0.686005599701508
BID,BH3-interacting domain death agonist,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23342,526,1.01 [0.90-1.13],0.8728820356961604
